DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

JP Morgan Maintains Neutral on Ionis Pharmaceuticals, Raises Price Target to $60

JP Morgan maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Neutral and raises the price target from $58 to $60.

Benzinga · 03/09/2020 12:17

JP Morgan maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Neutral and raises the price target from $58 to $60.